Table 2.
Mycobacteriae that could be grown by diagnoses
| Number of individuals / tissue where isolation was realized | |||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Diagnosis | M. bovis | M. chelonae | M. elephantis | M bovis, M. fortiutum, M.tuberculosis and M. avium intracellulare | M.fortiutum and M.chlonea | M.tuberculosis | Total number of patients |
| CGD | 1 individual/liver | 0 | 0 | 0 | 0 | 3 individuals sputum and FGF | 4 |
| Partial defect of IFNGR2 | 1 individual/lymph node | 0 | 1 individual/lymph node | 0 | 0 | 0 | 2 |
| Complete defect of IFNGR1 | 0 | 0 | 0 | 1 individual/M. bovis and M.fortiutum in lymph node, M.tuberculosis in the bone marrow, M. avium intracellulare in FGF | 0 | 0 | 1 |
| IL12 R1 defect | 0 | 1 individual/lymph node | 0 | 0 | 1 individual/lymph node | 0 | 2 |
| SCID | 1 individual/skin abscess 3 individuals /lymph node | 0 | 0 | 0 | 0 | 0 | 4 |
| NEMO | 1 individual/skin abscess, CNS and lymph node | 0 | 0 | 0 | 0 | 0 | 1 |
| Total number of patients | 7 | 1 | 1 | 1 | 1 | 3 | 14 |
CGD: chronic granulomatous disease; FGF: fasting gastric fluid; IFNGR2: IFN-γ receptor 2; IFNGR1: IFN-γ receptor 1; IL12RB1: interleukin 12 receptor beta 1; NEMO: nuclear factor kappa beta essential modulator, SCID: severe combined immune deficiency